You are here

Offerings On Manhattan Street Capital

Success in hand
Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16th - two days left. Their Oncoprex medicine delivers DNA to lung cancer cells via custom nanoparticles and causes low side effects. The DNA string adjusts cell signaling to trigger cancer cell death. Genprex is raising $6.5 mill at a...
City with title
New and Updated Offerings live on Manhattan Street Capital ERC Homebuilders Investors in ERC Homebuilders receive an 8% per annum dividend, paid monthly from the date of...
Compass towards success
Genprex is raising capital through their IPO to progress Clinical trials for their Gene Therapy lung cancer treatment. Genprex has developed Oncoprex, a unique medicine...
hiking with friend
ERC Homebuilders Inc. - Max raise $50mill. Anyone can invest ERC develops "build-to-rent" homes to capitalize on market demand driven by the cultural wave of millennials...
Handshake at golf
I am pleased to announce two new offerings on Manhattan Street Capital, TransCode Therapeutics and GolfSuites 1, and update you on our platform's ongoing offerings....
investing button
Reg A+ offerings - Anyone can invest   GolfSuites 1 - Anyone can invest "GolfSuites is a new investment opportunity focused on bringing hybrid-golf...
Pointing at title
Most active Reg A+ offerings on Manhattan Street Capital GolfSuites 1 Investors in GolfSuites 1 receive an 8% per annum dividend (see the Offering Circular for the...
Adjusting puzzle in sunset
Muscle Maker, Inc. Reg A+ IPO Raising $20 mill at $51 mill pre-money valuation, plans to List on the NYSE in January. Underwritten by Tripoint. Muscle Maker Grill is a...
Bitcoin mining
BitPlus - Mining Bitcoin and other cryptocurrencies with ultra-low cost and high efficiency, live to investors. The people who made the most money in the gold rush were...